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Abstract
Background: India has the third largest HIV-1 epidemic with 2.4 million infected individuals. Molecular epidemiological
analysis has identified the predominance of HIV-1 subtype C (HIV-1C). However, the previous reports have been limited by
sample size, and uneven geographical distribution. The introduction of HIV-1C in India remains uncertain due to this lack of
structured studies. To fill the gap, we characterised the distribution pattern of HIV-1 subtypes in India based on data
collection from nationwide clinical cohorts between 2007 and 2011. We also reconstructed the time to the most recent
common ancestor (tMRCA) of the predominant HIV-1C strains.
Methodology/Principal Findings: Blood samples were collected from 168 HIV-1 seropositive subjects from 7 different
states. HIV-1 subtypes were determined using two or three genes, gag, pol, and env using several methods. Bayesian
coalescent-based approach was used to reconstruct the time of introduction and population growth patterns of the Indian
HIV-1C. For the first time, a high prevalence (10%) of unique recombinant forms (BC and A1C) was observed when two or
three genes were used instead of one gene (p,0.01; p=0.02, respectively). The tMRCA of Indian HIV-1C was estimated
using the three viral genes, ranged from 1967 (gag) to 1974 (env). Pol-gene analysis was considered to provide the most
reliable estimate [1971, (95% CI: 1965–1976)]. The population growth pattern revealed an initial slow growth phase in the
mid-1970s, an exponential phase through the 1980s, and a stationary phase since the early 1990s.
Conclusions/Significance: The Indian HIV-1C epidemic originated around 40 years ago from a single or few genetically
related African lineages, and since then largely evolved independently. The effective population size in the country has been
broadly stable since the 1990s. The evolving viral epidemic, as indicated by the increase of recombinant strains, warrants
a need for continued molecular surveillance to guide efficient disease intervention strategies.
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Introduction
India has a burden of 2.4 million people infected with human
immunodeficiency virus type 1 (HIV-1) making it the third largest
HIV-1 epidemic in the world after South Africa and Nigeria
(National AIDS Control Organization, Annual Report 2011,
http://nacoonline.org.). HIV-1 in India was first identified among
female sex workers in Tamil Nadu in 1986 [1]. Molecular
epidemiological analysis has identified the predominant subtype as
subtype C (HIV-1C), irrespective of route of transmission [2–5].
Most of the reports have been limited by sample size, uneven
geographical distribution and the number of viral genes studied
[6–8]. A recent study categorized all reported HIV sequences from
India into two periods (2000 to 2003 and 2004 to 2007) and
identified a dominance of HIV-1C, which constituted 96.5% and
97.8% of all infections, respectively, although inherent biases of
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39819small sample size and simplified subtyping methods were
acknowledged as study limitations [9].
The reconstruction of the time to most recent common ancestor
(tMRCA) of HIV-1C in Africa has been dated back to the early
1950s [10,11]. Studies have also been conducted to identify the
origin and tMRCA of subtype C in Malawi [12], southern
America [13,14], Zimbabwe [15], Ethiopia [16] and the UK [17].
A recent report dated the tMRCA of HIV-1C in India back to the
mid- to late of the 1970s [18,19]. Although the estimate is
indicative, the assessment was based on a relatively small number
of sequences, retrieved from a secondary database, with little
knowledge of the geographic origins. These factors introduce an
element of uncertainty to the estimate, which could be overcome
using a larger sample of sequences with known origins from
different parts of the country. Furthermore, studies based on
a single gene analysis may suffer from a limitation in that the rate
of evolution of the viral genes may differ significantly due to the
variable selection pressure exerted by host factors [10]. As
a consequence the actual date of viral introduction may be
underestimated [14].
The present study is a comprehensive investigation of the
molecular epidemiology of the HIV-1 subtypes circulating in India
based on a large number of clinical samples representing different
geographic regions using three different viral genes gag, pol and env.
To trace the date of introduction of HIV-1C in India, we
generated datasets representing seven states of the country; Punjab
and Haryana (northern region), Manipur (north-eastern region),
Madhya Pradesh (central region), Karnataka, Andhra Pradesh and
Tamil Nadu (southern region). Additionally, sequences represent-
ing the state of Maharashtra (the western region) were downloaded
from the databases. Our study thus represents the first nationwide
study to examine the molecular distribution of the circulating
HIV-1 subtypes in India and to trace the tMRCA of the
predominant subtype C strains.
Results
A total of 168 samples were used representing the northern
(n=27), north-eastern (n=15), central (n=25) and southern
(n=101) regions of India. The gag, pol and env gene segments were
amplified from 164 (97.6%), 120 (71.4%) and 158 (94%) samples,
respectively. The three genes gag/pol/env were amplified from 107
patients; gag/pol from 116, gag/env from 155 and pol/env from 110
individuals. The patient clinical and demographic characteristics
were as follows: mean age was 36 years (SD69) and 55.4% (93/
168) were male. The predominant route of transmission was
heterosexual in 89.9% (151/168) of the subjects, while the
remaining were intravenous drug users (8.9%; 15/168) and
perinatal transmission (1.2%; 2/168). Median CD4 count (avail-
able for 141 patients) was 213 cells/mm
3 (IQR: 120–339) and
mean viral load (available for 80 patients) was 5.5 Log10 copies/
Figure 1. Prevalence of HIV-1 subtypes and recombinant forms in India based on one gene, two and three genes. The p values are
presented along with the values for the predominant HIV-1C and recombinants. Subtyping was carried out as described in the methods section. For
sequences that indicated an event of recombination, bootscan analysis was performed in Simplot version 3.5.1 using 100 nucleotide window size and
20 nucleotide step size to map the precise breakpoint. The recombination event was further confirmed by region-specific phylogenetic analysis using
ML tree in MEGA 5.
doi:10.1371/journal.pone.0039819.g001
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for 115 patients was 12 months (Range 0–130 months). All the
patients were therapy naı ¨ve.
HIV-1 Subtyping
Subtyping analysis confirmed the predominance of HIV-1C
strains in India. The prevalence of recombinants depended on
whether one or more genes were analyzed. When a single gene
was used for the subtype determination the mean proportion of
HIV-1C, B and A1 were 95.9%, 1.9% and 0.2%, respectively,
while the recombinants constituted 2.1%. A significant increase
was observed in the prevalence of recombinant strains when two
genes or three genes were used for subtype determination (10.1%;
17/168, p,0.01; 9.4%; 10/107, p=0.02) (Figure 1).
Among the four geographical regions examined, a high pro-
portion of recombinant strains was identified in north-eastern
(46.7%; 7/15) and northern (18.5%; 5/27) India (Figure 2). While
in central India, all strains were identified as HIV-1C and in
southern India 5.0% of the strains (5/101) were identified to be
recombinant. Of the recombinant strains, 6.0% (10/168) were
recombinants of subtypes B and C, whereas 4.2% (7/168) were
recombinants of A1 and C. Furthermore, these 17 recombinant
strains represented a large magnitude of genetic diversity - at least
five different B-C and three different A1-C recombinants (Table 1).
All the identified HIV-1B and A1 strains in the single gene analysis
turned out to be recombinant strains when two or three viral genes
were taken into considerations. The genetic configuration of all
recombinant strains has been depicted (Table 1). It has to be noted
that out of the 17 recombinant strains, four BC recombinant stains
showed recombination breakpoint in the pol gene while three A1C
recombinant strains showed recombination breakpoint in the env
gene. Also, the number of degenerate bases were low in all
samples, which were classified as recombinant strains, thus
eliminating the possibility of dual infection. The nearest sequence
analysis using BLAST identified that the subtype B segments in the
BC recombinant strains as derived most likely from China and
Thailand while the A1 segment in A1C originated from eastern
Africa (Kenya, Uganda and Tanzania). These results were further
confirmed by the maximum likelihood (ML) tree.
Date of Origin of the Predominant HIV-1C Strains in India
The tMRCA estimates using three viral genes ranged from year
1967 (gag) (95% CI: 1957–1975) to 1974 (95% CI: 1968–1978)
(env), with the estimate for the pol-gene falling in between at 1971
(95% CI: 1965–1976) (Figure 3). The overall median and mean
values for the three genes were found to be 1971 and 1970,
respectively. The tMRCA analysis showed a good convergence
and high effective sample size (ESS) values (.200) for most
parameters of all three genes. For gag and env, however, a small
number of Indian strains fell outside of the main Indian clade in
the final tree. Since the outlier viral strains were also included in
the taxon set for the Indian tMRCA calculations, it resulted in
poor convergence and low ESS (,200) of this parameter. This
problem, however, was not manifested in the pol-gene analysis.
Therefore the pol-gene analysis is likely to provide the most reliable
estimate for the India C tMRCA (1971), which agreed well with
the overall mean and median values.
The Geographical Source of HIV-1C in India
Our data points towards a first introduction of HIV-1 in India
around 40 years ago and at that time, subtype C had recently
emerged and the intra-subtype divergence seen today had not yet
arisen. It was not possible to determine from which country the
first introduction took place, as the main Indian clade of the pol-
tree are equidistant to all strains in the neighboring clade. The
relative lack of intermingling between Indian and African strains
suggest that the main Indian HIV-1C epidemic has largely evolved
independently over the last four decades, and that later trans-
mission events between these regions have only caused a minor
contribution to the overall prevalence in the Indian states included
in this study.
Phylogenetic Analysis and the Migration Pattern of HIV-1
Subtypes in India
Phylogenetic analyses of the three viral genes showed that a large
majority of all Indian HIV-1C strains included in the analysis
(91.3% for gag, 95.7% for env and 95.5% for pol) clustered together
in the main Indian clades (Figure 3). This shows that most
infections are acquired within the country, but detailed regional
transmission patterns could not be discerned. An intense admixing
was observed among the northern, western, central and southern
Indian strains. The pol phylogenetic tree identified a small clade
mainly consisting of the strains from western, central and north-
eastern regions of the country, indicating movement of strains
among these regions (data not shown).
Population Growth Dynamics
The Bayesian skyline plot (BSP) is used to draw an inference of
the estimation of the effective population size (the number of
infected individuals contributing to the spread of the disease) over
time directly from the sequence data [20]. The demographic
history from the pol BSP identified three epidemic growth phases
(Figure 4), an initial slow growth phase until the mid1970s
followed by an exponential growth phase till the late 1980 and
early 1990s followed by a stationary phase, approaching the
present time. A similar pattern was observed for env and gag BSP.
Discussion
The present study reports for the first time the molecular
epidemiology of the Indian HIV-1 epidemic using sequences of
three structural genes (gag, pol and env) derived from multiple
clinical cohorts across the country. Based on this high quality data
set, we found a high prevalence of recombinant strains in India
Also, our analysis suggests that the most recent common ancestor
of the HIV-1C epidemic in India is dated between 1967 and 1974,
more precisely in 1971, approximately five years earlier than
previous estimates [18,19].
All of the previous studies of the molecular epidemiology of the
Indian HIV-1 epidemic have used a few geographically localized
samples and a single viral gene [5–8,21,22]. A recent such study of
global trends in the molecular epidemiology of HIV-1 identified
1.06% recombinant strains (CRFs and URFs) in India between
2000 and 2007 [9]. Our own observations were comparable for
the period between 2007 and 2011 when a single viral gene was
used in the analysis. However, when two or three viral genes were
included, a higher proportion of HIV-1 recombinant strains were
found than has been reported earlier [22–26]. The mosaic
structure in our recombinants indicates that URFs might have
been formed in the local epidemic due to migration of strains.
Some of these URFs are likely to mature into CRFs as they
continue to circulate among the populations.
In our study, URFs were more prevalent in these northern and
north-eastern regions of India. This outcome, however, must be
interpreted with caution given that the numbers of strains analysed
from these two regions were relatively small. Previous reports from
northern [22] and north-eastern [26] regions of India demon-
strated relatedness to the subtype B segments from China and
HIV-1C Origin and Evolutionary History, India
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been reported that the Indian subtype C was one of the parental
strains of CRF07_BC and CRF08_BC [18]. Thus, the data from
our analysis and the previous studies collectively suggest an
expansion of the HIV-1 URFs in the northern and north-eastern
regions of India. Cross border networking among the intravenous
drug users may be the driving force of the spread of recombination
in these regions. Furthermore, our data indicate that the
transmission of the subtype A1 segment of the A1C recombinants
in India most likely occurred from eastern Africa. Continual
migration between Africa, especially eastern and southern, and
India, for business and migrant labour has been going on for
centuries, and this well established trade route may explain the
spread.
The tMRCA of HIV-1C in Africa has been dated into 1950s.
Our estimates of the tMRCA of Indian HIV-1C to be between
1967 and 1974 allude to the presence of HIV-1C in Indian nearly
two decades prior to its detection in 1986 [1]. The time of
introduction of HIV-1C in India is somewhat later than that of
Ethiopia (1965) [16] and Zimbabwe (early 1970s) [15], but
precedes that in Brazil (early 1980s) [13] and the United Kingdom
(1980s) [17]. This would indicate that HIV-1C was introduced in
India at an early stage of the global subtype C epidemic and that it
is likely to be the oldest HIV-1C epidemic outside Africa.
The population dynamics described in this report indicates the
growth of the effective infected population size in three phases.
The data corresponds well with the HIV-1 estimates in India,
which indicate a stable or reverse HIV prevalence between 2002
and 2009 (National AIDS Control Organization, Annual Report
2011, http://nacoonline.org.). Our molecular data are also in line
with the success of the strategic plan for the HIV prevention, the
National AIDS Control Program (NACP) launched by Govt. of
India in the 1990s. Targeted interventions through NACP –I-III
to high risk group populations and the scale up of this program
coincides with the stabilization of the epidemic as observed in our
BSP.
Our study has some limitations. First, the depth of the
sampling is relatively low given the HIV-1 estimates in the
country. In order to more accurately analyze the spread of
HIV-1C within the subcontinent, a further increase of the
Figure 2. Distribution of HIV-1 subtypes and recombinants in the clinical cohorts based on two genes. The regions [southern
(Karnataka, Tamil Nadu and Andhra Pradesh), northern (Punjab and Haryana), north-eastern (Manipur) and central (Madhya Pradesh)] from where the
samples were collected are shown in colors. The pie chart depicts the percentage of subtypes and recombinant strains in respective regions.
doi:10.1371/journal.pone.0039819.g002
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Second, the present analysis was restricted to mainly hetero-
sexual transmission and only a few samples from intravenous
drug users and perinatal transmission. Third, Bayesian co-
alescent method has some limitations to conclude the population
demography as the deleterious mutations may result in over-
estimating the tMRCA. Fourth, we have a large number of
samples from southern India compared to the other regions.
However a technical merit of our study is the large data set
with known clinical, demographical, sampling date and geo-
graphic origin. The multiple gene analysis for HIV-1 subtyping
also minimizes the use of the subtype C segments of
recombinant strains in the dataset to estimate the tMRCA.
In conclusion, our study identified a significant increase in the
prevalence of recombinant strains (URFs) in India by the
application of robust subtyping methods. The introduction of
HIV-1C into India was dated back to around 1971, and we found
that the epidemic has been stable for over a decade. Our results
indicate that HIV-1C was likely to have been introduced into
India at an early stage of the global HIV-1 epidemic and that
India harbors one of the oldest HIV-1C epidemics worldwide
outside Africa. As the depth of sampling (the proportion of
available sequences to infections) is still very low in India the
resulting diversified epidemiology may pose serious challenges to
the development of an effective vaccine that would be applicable
in the country. Ongoing country wide molecular surveillance of
HIV-1 is likely to contribute towards a better understanding of the
epidemiology in this region.
Materials and Methods
Study Population
Blood samples were obtained between 2007 and 2011 from
HIV-1 infected seropositive subjects (n=168) hailing from
different regions of India including northern (Punjab and
Haryana), southern (Karnataka, Tamil Nadu and Andhra
Pradesh), north-eastern (Manipur) and central (Madhya Pradesh)
regions. Written informed consent was obtained. Genomic DNA
was extracted from whole blood using QIAamp Blood DNA kit
(Qiagen, Germany) and stored at 280uC until used.
Polymerase Chain Reaction and Sequencing
HIV-1 p17 region gag (HXB2 position 790–1190), RT region of
pol (HXB2 position 2598–3254) and C2V4 region of env (HXB2
position 7050–7550), respectively, were amplified by nested
polymerase chain reaction (PCR) using iNtRON Taq Polymerase
(Intron Biotech, South Korea) as described previously [5,21,27].
The following amplification conditions were common for all three
genes were: 1 cycle at 95uC for 2 min, 3 cycles at 94uC for 1 min,
55uC for 1 min and 72uC for 3 min, followed by 32 cycles at 94uC
for 1 min, 60uC for 1 min and 72uC for 3 min with a final
extension at 72uC for 10 min. Two ml PCR product from the first
round was used as template in the second round nested PCR, with
1 cycle at 94uC for 2 min, 3 cycles at 94uC for 1 min, 55uC for
30 sec and 72uC for 3 min, followed by 32 cycles at 94uC for
1 min, 60uC for 1 min and 72uC for 1 min with a final extension
at 72uC for 5 min. Bidirectional sequencing was carried out using
the second round PCR primers.
Table 1. Genetic make-up of recombinant clinical strains.
PID gag pol env Nearest Strains (non-C subtype region) Recombinant*
RIP REGA RIP REGA RIP REGA
08NIIPGI01
a B B Not amplified C C Thailand URF_BC
08NIIPGI12
a B B Not amplified C C China URF_BC
08NIIPGI14
a C C Not amplified A1, C C Kenya URF_A1C
08NIIPGI19
a B B Not amplified C C China URF_BC
09NIIPGI47
a C C Not amplified A1 NA Uganda URF_A1C
MNP01
b C C B, C NA C C Thailand URF_BC
MNP05
b CCB NA C C China URF_BC
MNP07
b C C B, C NA C C China URF_BC
MNP08
b C C B, C NA C C China URF_BC
MNP09
b B B B B C C China URF_BC
MNP11
b C C B, C NA B B China URF_BC
MNP15
b C C B B B, C NA China/Thailand URF_BC
08JNC05
c C C Not amplified A1,C NA Kenya URF_A1C
09SJ08
c C C A1 A1 C C Cyprus URF_A1C
09SJ56
c Not amplified C C A1, C NA Kenya URF_A1C
10SJ02
c CC C C A 1 NA Iran URF_A1C
11SJ74
c C C Not amplified A1 A1 Tanzania URF_A1C
aSamples from northern India,
bNorth-eastern India and
cSouthern India. The recombinants were identified based on atleast two of the three viral genes, gag, pol and
env. Recombination Identification Program ver 3.0 (RIP) and REGA subtyping tool ver 2 (REGA) were used. Recombinant strains were further confirmed by bootscan
analysis in Simplot version 3.5.1 using 100 nucleotide window size and 20 nucleotide step size to map the precise breakpoint and region-specific phylogenetic analysis
using ML tree in MEGA 5. NA: Not Assigned.
doi:10.1371/journal.pone.0039819.t001
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Reference sequences (2010) of different subtypes (n=170) were
downloaded from HIV-1 Los Alamos Database (‘‘LANL’’, www.
hiv.lanl.gov). Subtyping of the clinical strains was initially inferred
using a maximum likelihood (ML) phylogenetic tree constructed
with general time reversal substitution model with inverse gamma
distribution (GTR+G+I) and 1000 bootstrapped data sets, using
the Molecular Evolutionary Genetics Analysis software version 5
(MEGA 5) [28]. The gene segments showing clustering with
different subtypes for a patient were further used for recombinant
screening in Recombination Identification program version 3 (RIP
3.0). To confirm consistent results, REGA HIV-1 Subtyping Tool
- version 2.0 was also used.
Detection of Recombination Events
Different gene segments from an individual showing different
subtype clusters were used for the recombination screening.
BLAST analysis was performed to identify the nearest sequences
using the HIV BLAST tool found in LANL. Reference sequences
with nucleotide identity .95% were chosen for each of the clinical
strains along with previously determined recombinant strains BC
and A1C where all the three segments were available. Separate
ML trees were constructed using each of the gene segments. All
the clinical strains contributed equally to this analysis and no
identical reference sequences were included. The sequences which
showed recombination were further processed for detailed analysis
of recombination breakpoints in Simplot version 3.5.1 [23]. The
mosaic pattern of each unique recombinant form (URF) was
confirmed using phylogenetic analysis of the recombination
fragments.
Selection of Reference Strains for tMRCA Analysis
Reference sequences were selected among the full-length
subtype C sequences available at the Los Alamos database, since
they covered the env, gag and pol regions investigated in this study.
Eleven Indian subtype C sequences with a known sampling year
Figure 3. Annotated phylogenetic trees for the gag- (Panel A), env (Panel B) and pol- (Panel C) genes. Phylogenetic trees were
constructed using the Indian HIV-1 subtype C from clinical samples taken from different parts of India (shown in green), including southern
(Karnataka, Tamil Nadu and Andhra Pradesh), northern (Punjab and Haryana), north-eastern (Manipur) and central (Madhya Pradesh) regions of India
plus data base retrieved reference sequences from western India and other countries, and two out-group subtype B strains. The Indian tMRCA
included in this study were shown with an arrow. Pol-gene analysis was considered to provide the most reliable estimate of tMRCA (shown with a red
arrow) for Indian HIV-1C, indicating around 1971 (95% CI: 1965–1976)]. Posterior probability plots showing the tMRCA estimates of Indian
HIV-1C (Panel D): The posterior probability density plots for the three genes (env, pol and gag) point to a tMRCA for Indian HIV-1C from 36.9 (env),
40.5 (pol) and 44.3 (gag) years ago, with an overall mean for the combined graph at 40.6 years ago before 2011, that is in 1970.4 (95% CI: 1960.3–
1978.1).
doi:10.1371/journal.pone.0039819.g003
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sequences were also included. In addition, subtype C sequences
from this alignment were selected so that all unique combinations
of different countries and sampling years were represented once, in
order to maintain as much genetic diversity as possible (n=45).
These strains originated from a total of 20 different countries,
located in southern Africa (Botswana, Malawi, South Africa,
Zambia, N=18), eastern Africa (Ethiopia, Kenya, Somalia and
Tanzania, N=9); and rest of the world (Argentina, Brazil, Cyprus,
Denmark, Germany, Israel, Myanmar, Senegal, Spain, Uruguay,
USA and Yemen, n=18). All the selected reference HIV-1C
sequences included in the analysis had the three genes of interest.
Two reference subtype B strains were included as out-group. The
final data sets, after sequence cleansing and gap stripping, included
196 taxa, 345 sites (gag), 159 taxa, 654 sites (pol), and 188 taxa, 407
sites (env), respectively.
Estimating Time to the Most Recent Common Ancestors
(tMRCA)
Alignments were performed in ClustalX2 [29] and phylogenetic
analyses were performed in BEAST v.1.6.2 [20]. Analysis in
jModelTest [30] showed that the GTR substitution model with
inverse gamma distribution was the best fitting model for all three
data sets and it was used in all BEAST runs. Two molecular clock
models (‘Relaxed: exponential’ and ‘Relaxed: log-normal’) were
tested in combination with four different coalescent tree priors
(‘Constant Size’; ‘Exponential Growth’, ‘Logistic Growth’ and
‘Bayesian Skyline’). The resulting log-files were analyzed in Tracer
v.1.6.2 [20] and the Bayes Factor analysis showed that the relaxed
log-normal clock with Bayesian Skyline was the most appropriate
model for all three genes. The taxon sets analyzed were ‘‘Subtype
C’’, which included all subtype C strains, and ‘‘India C’’, which
included all Indian strains from this study. Tip dates (year of
sampling for each sequence) together with a previous estimate of
the age of subtype C into the year 1952 [10] were used for
calibration of the molecular clock (the prior was set to Normal
distribution, 49 +/2 6 years since the last year of sampling, 2011),
and rates of evolution were automatically calculated from these
data. The analyses were run for 100 million generations, with
sampling every 10,000 generation, and the sampled trees were
annotated using TreeAnnotator v1.6.2 and visualized in FigTree
v1.3.1 (http://tree.bio.ed.ac.uk/software/figtree/).
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